Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:22:28 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:GILD - GILEAD SCIENCES INC - http://www.gilead.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GILD - Q0.166.66·66.909.266.76+0.600.910,656.8707,10044,36566.36  66.825  66.1687.865  66.8917:43:17Apr 1815 min RT 2¢

Recent Trades - Last 10 of 44365
Time ETExPriceChangeVolume
17:43:17Q66.750.5920
17:27:52Q66.750.597
17:14:31Q66.660.501
17:03:15Q66.760.601
16:56:50Q66.760.6050
16:51:39Q66.760.60100
16:51:39Q66.760.60100
16:51:39Q66.760.60100
16:51:39Q66.760.60100
16:23:39Q66.760.6050

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-18 13:47U:GILDNews ReleaseGilead Sciences Publishes 2023 ESG Impact Report
2024-04-08 16:05U:GILDNews ReleaseGilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
2024-04-02 09:17U:GILDNews ReleaseGilead Sciences Champions Equal Pay
2024-03-28 08:30U:GILDNews ReleaseFDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
2024-03-28 07:00U:GILDNews ReleaseGilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
2024-03-26 09:18U:GILDNews ReleaseWinn Awards Help Physicians Solve Healthcare Disparities
2024-03-22 09:18U:GILDNews ReleaseGilead Sciences Announces Completion of Acquisition of CymaBay
2024-03-19 09:08U:GILDNews ReleaseGilead Helps Launch Turkiye's First HIV Testing Week
2024-03-18 19:29U:GILDNews ReleaseCenter for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
2024-03-12 08:47U:GILDNews ReleaseGilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations
2024-03-11 08:24U:GILDNews ReleaseGilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer
2024-03-07 08:17U:GILDNews ReleaseGilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing
2024-03-06 16:30U:GILDNews ReleaseBiktarvy(TM) Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities
2024-03-06 10:25U:GILDNews ReleaseGilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
2024-03-06 08:00U:GILDNews ReleaseGilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
2024-03-05 16:35U:GILDNews ReleaseNew Real-World Data Further Support the Use of Veklury(TM) (Remdesivir) for People Hospitalized With COVID-19
2024-03-05 16:30U:GILDNews ReleaseGilead's Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health
2024-03-05 08:47U:GILDNews ReleaseGilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
2024-02-29 08:33U:GILDNews ReleaseGilead Sciences: National Black HIV/AIDS Awareness Day